Recent patent applications in stem cell research

April 2006
Nature Biotechnology;Apr2006, Vol. 24 Issue 4, p414
Academic Journal
The article presents a list of recent patent applications in stem cell research. The subjects of the patents include a method of regulating cell function of a stem cell, a commercial product for culturing human embryonic stem cells, and a method of producing a marker capable of identifying an embryonic stem cell and embryonic carcinoma cell.


Related Articles

  • Human embryonic stem cells: The future is now. Keller, Gordon; Snodgrass, H. Ralph // Nature Medicine;Feb1999, Vol. 5 Issue 2, p151 

    The development of human embryonic stem cells as a research tool and therapeutic option offers a number of potential applications including the replacement of damaged tissues.

  • Corrigendum: Quantifying cell-generated mechanical forces within living embryonic tissues. Campàs, Otger; Mammoto, Tadanori; Hasso, Sean; Sperling, Ralph A; O'Connell, Daniel; Bischof, Ashley G; Maas, Richard; Weitz, David A; Mahadevan, L; Ingber, Donald E // Nature Methods;Mar2014, Vol. 11 Issue 3, p349 

    A correction to the article related to quantifying cell-generated mechanical forces in living embryonic tissues is presented.

  • Embryonic stem cells: the moral dilemma of patentability and funding. San Martín, Beatriz // Pharmaceutical Technology Europe;Sep2009, Vol. 21 Issue 9, p50 

    The article discusses the increasing moral debate concerning the patentability and finance of human embryonic stem cells (hES) development in Europe. The author asserts that hES cell research has gained wide interest from scientist because it contains since it allows them to gain better...

  • The gatekeepers of hES cell products. Rabin, Sander // Nature Biotechnology;Jul2005, Vol. 23 Issue 7, p817 

    The article focuses on commercial products derived from human embryonic stem cells (hES). Access to hES cells is presently mediated by a political, legal and economic infrastructure assembled on the foundation of two U.S. patents. Since 2001, federal regulations have divided hES cell research...

  • Derivation of Chondrogenically-Committed Cells from Human Embryonic Cells for Cartilage Tissue Regeneration. Hwang, Nathaniel S.; Varghese, Shyni; Elisseeff, Jennifer // PLoS ONE;2008, Vol. 3 Issue 6, p1 

    Background: Heterogeneous and uncontrolled differentiation of human embryonic stem cells (hESCs) in embryoid bodies (EBs) limits the potential use of hESCs for cell-based therapies. More efficient strategies are needed for the commitment and differentiation of hESCs to produce a homogeneous...

  • Ethical, scientific breakthroughs seen in new stem-cell studies.  // National Catholic Reporter;12/7/2007, Vol. 44 Issue 6, p3 

    The article reports on the study of human skin cells by scientists and ethicists in the U.S. The study shows that human skin cells can be reprogrammed to work as effectively as embryonic stem cells, which genetically match the donor and have the ability to become any of the 220 types of cells in...

  • Human iPS Cells: Science and Ethics. Crook, Jeremy Micah // Open Stem Cell Journal;2010 Special Issue, p1 

    An introduction to the journal is presented in which the editor discusses articles on the science and ethic of human induced pluripotent stem (iPS) cells, the human somatic cell reprogramming, and the biological equivalent of the iPS and embryonic stem (ES) cells.

  • Patent watch.  // Nature Reviews Drug Discovery;Oct2002, Vol. 1 Issue 10, p750 

    Reports on developments concerning patents in Europe and the United States as of October 2002. Oral proceedings of the Opposition Division of the European Patent Office concerning the use of genetic engineering to isolate stem cells from more differentiated cells to obtain pure stem-cell...

  • Opponents of stem-cell patent win restrictions. Abbott, Alison; Schmidt, Oliver // Nature;8/1/2002, Vol. 418 Issue 6897, p470 

    Reports on the restriction in the scope of patent covering technologies for purifying human and animal embryonic stem cells by the European Patent Office in 2002. Details of the patent coverage; Groups that filed objections to the patent; Claim against the methods involved in the patent; Basis...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics